16 cents increase - not considering that - OTCPINK- no other coverage in any publication - limited audience that can buy the stock Low credibility assigned to this stock
Today's PR contained so many news that a big pharma would be envious of it. If this stock was on Nasdaq or even OTCQB - we would have seen around 10%+ increase easily